BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 8093509)

  • 1. Sumatriptan.
    Bateman DN
    Lancet; 1993 Jan; 341(8839):221-4. PubMed ID: 8093509
    [No Abstract]   [Full Text] [Related]  

  • 2. Sumatriptan for migraine.
    Med Lett Drugs Ther; 1992 Oct; 34(880):91-3. PubMed ID: 1326077
    [No Abstract]   [Full Text] [Related]  

  • 3. Sumatriptan: efficacy and contribution to migraine mechanisms.
    Pearce JM
    J Neurol Neurosurg Psychiatry; 1992 Dec; 55(12):1103-5. PubMed ID: 1336041
    [No Abstract]   [Full Text] [Related]  

  • 4. SUMATRIPTAN: a receptor-targeted treatment for migraine.
    Moskowitz MA; Cutrer FM
    Annu Rev Med; 1993; 44():145-54. PubMed ID: 8386498
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and experimental effects of sumatriptan in humans.
    Ferrari MD; Saxena PR
    Trends Pharmacol Sci; 1993 Apr; 14(4):129-33. PubMed ID: 8390743
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Building on the sumatriptan experience: the development of naratriptan.
    Connor HE
    Cephalalgia; 2001; 21 Suppl 1():32-4. PubMed ID: 11678820
    [No Abstract]   [Full Text] [Related]  

  • 7. Eletriptan.
    Gawel MJ; Grujich NN
    Expert Opin Investig Drugs; 2001 Oct; 10(10):1869-74. PubMed ID: 11772292
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sumatriptan for the treatment of migraine attacks--a review of controlled clinical trials.
    Tfelt-Hansen P
    Cephalalgia; 1993 Aug; 13(4):238-44. PubMed ID: 8397070
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Subcutaneous sumatriptan does not abort attacks of chronic paroxysmal hemicrania (CPH).
    Dahlöf C
    Headache; 1993 Apr; 33(4):201-2. PubMed ID: 8388371
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of sumatriptan on visual aura symptoms in migraine.
    Schoenen J
    Headache; 1993 Mar; 33(3):164. PubMed ID: 8387475
    [No Abstract]   [Full Text] [Related]  

  • 11. Sumatriptan: new relief for migraine headaches.
    Holdcroft C
    Nurse Pract; 1993 Jul; 18(7):11, 14. PubMed ID: 8394559
    [No Abstract]   [Full Text] [Related]  

  • 12. Neurogenic versus vascular mechanisms of sumatriptan and ergot alkaloids in migraine.
    Moskowitz MA
    Trends Pharmacol Sci; 1992 Aug; 13(8):307-11. PubMed ID: 1329294
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Migraine revolution and sumatriptan.
    Palmer JB; Salonen R
    Lancet; 2000 Jun; 355(9222):2250-1. PubMed ID: 10881915
    [No Abstract]   [Full Text] [Related]  

  • 14. Efficacy of subcutaneous sumatriptan in repeated episodes of migraine.
    Cady RK; Dexter J; Sargent JD; Markley H; Osterhaus JT; Webster CJ
    Neurology; 1993 Jul; 43(7):1363-8. PubMed ID: 8392150
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Improved pharmacokinetics. Fast tryptan with sustained response].
    MMW Fortschr Med; 2003 May; 145 Suppl 2():106-7. PubMed ID: 14579498
    [No Abstract]   [Full Text] [Related]  

  • 16. Treatment of migraine attacks with subcutaneous sumatriptan: first placebo-controlled study. The Subcutaneous Sumatriptan International Study Group.
    Visser WH; Ferrari MD; Bayliss EM; Ludlow S; Pilgrim AJ
    Cephalalgia; 1992 Oct; 12(5):308-13. PubMed ID: 1330318
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sumatriptan: a selective 5-hydroxytryptamine receptor agonist for the acute treatment of migraine.
    Fullerton T; Gengo FM
    Ann Pharmacother; 1992 Jun; 26(6):800-8. PubMed ID: 1319244
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sumatriptan. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in the acute treatment of migraine and cluster headache.
    Dechant KL; Clissold SP
    Drugs; 1992 May; 43(5):776-98. PubMed ID: 1379152
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The safety of sumatriptan in asthmatic migraineurs.
    Lloyd DK; Pilgrim AJ
    Cephalalgia; 1993 Jun; 13(3):201-4. PubMed ID: 8395345
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sumatriptan: a new serotonin agonist for the treatment of migraine headache.
    Susman JL
    Am Fam Physician; 1993 Feb; 47(3):645-7. PubMed ID: 8382004
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.